Injury-Retention Strategy for Discriminative Magnetic Resonance Imaging and Enhanced Antioxidant Therapy of Drug-Induced Liver Injury
Nano Letters · 2026
DOI: 10.1021/acs.nanolett.6c00050 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nano Letters, 2026. Verfasst von Xiaoge Xue und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China. Hauptthemen laut MEDLINE: Chemical and Drug Induced Liver Injury, Magnetic Resonance Imaging, Antioxidants, Ferrocyanides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Tongji Hospital, Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Drug-induced liver injury (DILI) is a prevalent cause of acute liver failure worldwide, characterized by impaired hepatic clearance which creates an opportunity for targeted nanomedicine. We present an injury-retention strategy for DILI management using a gadolinium hexacyanoferrate nanozyme (GdHF). This nanozyme enables simultaneous high-fidelity diagnosis and sustained treatment. It intrinsically combines high longitudinal relaxivity (r1 = 13.23 mM-1·s-1, 3.9-fold greater than Gd-DTPA) with multienzyme mimetic activities. In an acetaminophen-induced DILI model, GdHF specifically accumulated in injured liver tissue due to impaired clearance, generating strong MR contrast that clearly discriminated injured from healthy tissue. Concurrently, it provided sustained local therapy by scavenging reactive oxygen and nitrogen species (RONS). This dual action significantly alleviated oxidative stress, inflammation, and hepatocyte damage, demonstrating efficacy comparable or superior to N-acetylcysteine in delayed treatment scenarios. Our retention-based approach synchronizes precise imaging with localized antioxidant therapy, offering a promising strategy for DILI and other RONS-related pathologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai 200072, China.
- Department of Medical Imaging, Tongji Hospital, Shanghai Frontiers Science Center of Nanocatalytic Medicine, The Institute for Biomedical Engineering & Nano Science, School of Medicine, Tongji University, Shanghai 20006…
- Shanghai Research Institute for Intelligent Autonomous Systems, Tongji University, Shanghai 201210, China.
ORCID-Profile: Weitao Yang, Bingbo Zhang
Förderung
- National Key Research and Development Program of China
- Tongji Hospital
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
Zitieren
APA
Xue, X., Cui, T., Liu, D., Qiu, H., Wang, H., Yun, Y., Qiu, Y., Yang, W., & Zhang, B. (2026). Injury-Retention Strategy for Discriminative Magnetic Resonance Imaging and Enhanced Antioxidant Therapy of Drug-Induced Liver Injury. Nano Letters. https://doi.org/10.1021/acs.nanolett.6c00050
Vancouver
Xue X, Cui T, Liu D, Qiu H, Wang H, Yun Y, et al. Injury-Retention Strategy for Discriminative Magnetic Resonance Imaging and Enhanced Antioxidant Therapy of Drug-Induced Liver Injury. Nano Letters. 2026. doi:10.1021/acs.nanolett.6c00050
BibTeX
@article{Xue2026,
author = {Xue, Xiaoge and Cui, Tianming and Liu, Dinghua and Qiu, Han and Wang, Hui and Yun, Yanjing and Qiu, Yuyou and Yang, Weitao and Zhang, Bingbo},
title = {Injury-Retention Strategy for Discriminative Magnetic Resonance Imaging and Enhanced Antioxidant Therapy of Drug-Induced Liver Injury},
journal = {Nano Letters},
year = {2026},
doi = {10.1021/acs.nanolett.6c00050}
}
EUVIMED